These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9685832)

  • 1. Influence of the phosphate balance on the activity distribution of 99mTc-hydroxy-methylene diphosphonate. Experimental studies in the mouse.
    Cronhjort M; Sääf M; Sjöberg HE; Schnell PO; Jacobsson H
    Acta Radiol; 1998 Jul; 39(4):427-33. PubMed ID: 9685832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity in the gastrointestinal tract after administration of bone-seeking radiopharmaceuticals. Experimental studies in mice.
    Cronhjort M; Jonsson C; Nilsson SO; Garmelius B; Jacobsson H
    Acta Radiol; 1996 Sep; 37(5):785-90. PubMed ID: 8915294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
    Ghiron J; Volkert WA; Garlich J; Holmes RA
    Int J Rad Appl Instrum B; 1991; 18(2):235-40. PubMed ID: 2026500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sympathotropic drugs and the distribution of 99mTc-hydroxymethylene diphosphonate. Experimental studies in the mouse.
    Cronhjort M; Jonsson C; Jacobsson H
    Acta Radiol; 1999 May; 40(3):309-13. PubMed ID: 10335970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo studies with pentavalent technetium-99m dimercaptosuccinic acid.
    Lam AS; Puncher MR; Blower PJ
    Eur J Nucl Med; 1996 Dec; 23(12):1575-82. PubMed ID: 8929310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New bone-seeking agent: animal study of Tc-99m-incadronate.
    Shigematsu M; Shomi S; Iwao H; Ochi H
    Ann Nucl Med; 2002 Feb; 16(1):55-9. PubMed ID: 11922209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases.
    Pauwels EK; Blom J; Camps JA; Hermans J; Rijke AM
    Eur J Nucl Med; 1983; 8(3):118-22. PubMed ID: 6220908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-time ingestion of colas influences the activity distribution at bone scintigraphy: experimental studies in the mouse.
    Jacobsson H
    J Am Coll Nutr; 2008 Apr; 27(2):332-6. PubMed ID: 18689567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiopharmacokinetic data for 99mTc-ABP--a new radiopharmaceutical for bone scanning: comparison with 99mTc-MDP.
    Arteaga de Murphy C; Meléndez-Alafort L; Montoya-Molina CE; Sepúlveda-Méndez J
    Nucl Med Biol; 1997 Jan; 24(1):27-33. PubMed ID: 9080472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of accumulation of 99mTc-MDP to bone: correlation of in vivo data with in vitro data.
    Okamoto YM
    Radiat Med; 1997; 15(4):209-15. PubMed ID: 9311035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical comparison of 99mTc-DPD and two 99mTc-MDP agents.
    Vorne M; Vähätalo S; Lantto T
    Eur J Nucl Med; 1983; 8(9):395-7. PubMed ID: 6226527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
    Kumar V; Kumar D; Howman-Giles RB; Little DG
    Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial uptake of bone scintigraphic agents associated with increased pulmonary uptake.
    Bach-Gansmo T; Wien TN; Løndalen A; Halvorsen E
    Clin Physiol Funct Imaging; 2016 May; 36(3):237-41. PubMed ID: 25524030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
    Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
    Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
    Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
    J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of 99mTc-diphosphonates in newly formed bone matrix as a measure of bone lesion detectability.
    Schuemichen C; Krause T; Umbach G; Wolff T
    Nuklearmedizin; 1988 Feb; 27(1):8-11. PubMed ID: 3368337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A report on the incidence of intestinal 99mTc-methylene diphosphonate uptake of bone scans and a review of the literature.
    Ergün EL; Kiratli PO; Günay EC; Erbaş B
    Nucl Med Commun; 2006 Nov; 27(11):877-85. PubMed ID: 17021428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased technetium-99 m hydroxy diphosphonate soft tissue uptake on bone scintigraphy in chronic kidney disease patients with secondary hyperparathyroidism: correlation with hyperphosphataemia.
    Enevoldsen LH; Heaf J; Højgaard L; Zerahn B; Hasbak P
    Clin Physiol Funct Imaging; 2017 Mar; 37(2):131-136. PubMed ID: 26148143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative whole-body bone scintigraphy. II. Pharmacokinetics of osteotropic radiopharmaceuticals (author's transl)].
    Anger K; Aigner S; Bühler M; Umbach I
    Nuklearmedizin; 1980 Jul; 19(3):97-107. PubMed ID: 7465432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.